baber/WOPTO huggingface dataset:
Patent MY-141226-A (MY)
Title: Keyed system for connection of filter cartridge to filter holder
Inventor: REID ROGER P
IPC: B01D46/00
Filed: 2003-02-19
Abstract: EMBODIMENTS OF A KEY SYSTEM FOR FILTERS (10) AND THEIR CONNECTING HEADS/HOLDERS ARE SHOWN. THE FILTER CARTRIDGE AND ITS HOLDER EACH HAVE A KEYED SURFACE, ONE BEING A PROTRUDING “KEY” (34) AND ONE BEING A RECESSED “LOCK” (24). COOPERATION OF THESE KEYED SURFACES IS REQUIRED IN ORDER FOR THE FILTER CARTRIDGE (20) TO BE INSTALLED IN THE HOLDER, SO THAT MISMATCHED CARTRIDGES CANNOT BE INSTALLED INTO THE HOLDER, FOR EXAMPLE, TO PREVENT A PARTICULAR TYPE OF CARTRIDGE FROM BEING PLACED IN A FILTRATION OR OTHER PROCESS WHERE IT WOULD BE INAPPROPRIATE, OR UNDESIRED. THE KEYED SURFACES ARE SELECTIVELY LOCATE-ABLE PREFERABLY AT DIFFERENT CIRCUMFERENTIAL LOCATIONS ON A PERIMETER OF THE FILTER (10) AND A CORRESPONDING LOCATION ON A PERIMETER OF THE HEAD/HOLDER. THE PERIMETER MAY BE, FOR EXAMPLE, ON AN OUTER SHOULDER SURFACE OF A FILTER (10) AND AN INNER SURFACE OF A VALVE HEAD, OR ON OUTER AND INNER SURFACES OF CONNECTORS THAT PROVIDE A LIQUID SEAL BETWEEN THE FILTER (10) AND THE HEAD/HOLDER.
Patent MY-176456-A (MY)
Title: Method of vitamin e recovery
Inventor: BADLISHAH SHAM BAHARIN
Filed: 2003-06-04
Abstract: The present invention describes a process for the recovery of vitamin E from fatty acid distillate which comprises the steps of: hydrolysis of FAD to obtain a hydrolysate containing free fatty acids and vitamin E; neutralization and removal of free fatty acids contained in the said hydrolysate in the presence of an alkali, an alkyl alcohol and a non-polar solvent to obtain a vitamin E-rich fraction in the non-polar solvent; adsorption chromatographic separation of the said vitamin E-rich fraction in a non-polar adsorbent to adsorb vitamin E onto the said polar adsorbent and to obtain a first eluent containing non-vitamin E components; conducting a second elution of the said adsorption chromatographic separation by using a polar solvent to obtain a second eluent containing the said vitamin E; a solvent removal step to the said second eluent; to obtain a vitamin E concentrate of at least 50 % by weight.
Patent MY-143502-A (MY)
Title: Multi-layered firewall architecture
Inventor: SWANDER BRIAN D
IPC: G06F/
Filed: 2004-04-22
Abstract: A METHOD AND SYSTEM ARE PROVIDED FOR IMPLEMENTING A FIREWALL ARCHITECTURE IN A NETWORK DEVICE. THE FIREWALL ARCHITECTURE INCLUDES A PLURALITY OF NETWORK LAYERS, A FIRST FIREWALL ENGINE, AND ONE OR MORE CALLOUT MODULES.THE LAYERS SEND PACKETS AND PACKET INFORMATION TO THE FIRST FIREWALL ENGINE, MAINTAIN AND PASS PACKET CONTEXT TO SUBSEQUENT LAYERS, AND PROCESS THE PACKETS. THE FIRST FIREWALL ENGINE COMPARES THE PACKET INFORMATION TO ONE OR MORE INSTALLED FILTERS AND RETURNS AN ACTION TO THE LAYERS INDICATING HOW TO TREAT THE PACKET. THE CALLOUTS PROVIDE ADDITIONAL FUNCTIONALITY SUCH AS INTRUSION DETECTION, LOGGING, AND PARENTAL CONTROL FEATURES.
Patent MY-140196-A (MY)
Title: Roman style shade
Inventor: YU FU-LAI
IPC: A47H5/00
Filed: 2004-08-09
Abstract: A WINDOW COVERING HAVING A PLURALITY OF PANELS COMPRISING HEAD RAIL AND A PLURALITY OF PANELS SUSPENDED FROM THE HEAD RAIL BY A SECUREMENT MEMBER AND AT LEAST ONE OPENING MEMBER IS PROVIDED. EACH OF THE PLURALITY OF PANELS IS COLLAPSIBLE AND INCLUDES A PAIR OF OPPOSED LONGITUDINAL REGIONS.A BOTTOM RAIL MAY ALSO BE PROVIDED AND SUSPENDED FROM THE HEAD RAIL SUCH THAT THE PLURALITY OF PANELS ARE LOCATED BETWEEN THE HEAD RAIL AND THE BOTTOM RAIL.
Patent MY-143059-A (MY)
Title: Flexible bed assembly and associated apparatus thereof for collecting bodily waste
Inventor: LI IRENE TAN SWEE
IPC: A61G7/057
Filed: 2006-11-03
Abstract: FLEXIBLE BED ASSEMBLY AND ASSOCIATED APPARATUS THEREOF FOR COLLECTING BODILY WASTE A BED ASSEMBLY (10) FOR PERMITTING A USER TO URINATE AND 5 DEFECATE WHILE LYING IN THE BED ASSEMBLY. THE BED ASSEMBLY (10) COMPRISES A MATTRESS (12) THAT HAS A TRANSVERSELV- EXTENDING ACCESS CHANNEL (14) EXTENDING THROUGH IT THAT PERMITS A USER TO URINATE AND DEFECATE WHILE LYING ON THE MATTRESS. THE ACCESS CHANNEL (14) IS ADAPTED TO SLIDABLY 10 RECEIVE A WASTE RECEPTACLE PAN FOR COLLECTING WASTE FROM THE BED OCCUPANT. THE MATTRESS (12) HAS A GAP (16) POSITIONED UNDER THE TORSO PORTION OF THE OCCUPANT AND THE GAP DEFINES THE OPEN TOP OF THE ACCESS CHANNEL (14) . THE GAP (16) HAS A REMOVABLE NON-CORROSIVE SUPPORTING NET (18) OVER IT TO SUPPORT 15 THE BUTTOCKS OF THE OCCUPANT. THE SUPPORTING NET (18) IS PERFORATED TO ALLOW PASSAGE OF THE WASTE DOWNWARD INTO THE WASTE RECEPTACLE PAN. GUIDE ROLLERS ARE MOUNTED IN THE ACCESS CHANNEL FOR SLIDINGLY RECEIVING AND RETRACTING THE WASTE RECEPTACLE PAN. THE MATTRESS IS POSITIONABLE BETWEEN A IVING 20 POSITI-ON AND A SITTING POSITION TO PERMIT THE OCCUPANT TO URINATE AND DEFECATE IN A SEATED POSITION.
Patent MY-163578-A (MY)
Title: An automated cot surveillance system
Inventor: TOMAS HENRIQUE BODE MAUL
IPC: G06Q50/00
Filed: 2007-12-12
Abstract: THE PRESENT INVENTION RELATES TO AN AUTOMATED SURVEILLANCE SYSTEM FOR COT FOR MONITORING AN INFANT OR CHILD.  THE SAID AUTOMATED SURVEILLANCE SYSTEM COMPRISES OF AN ADEQUATELY POSITIONED VIDEO CAMERA (10), AN ADEQUATELY POSITIONED LIGHT SOURCE (12) AND WHEREIN PROCESSING THE RESULTING INFORMATION VIA INNOVATIVE COMPUTER VISION ALGORITHMS AND WHEREIN THE POSITIONING OF THE LIGHT SOURCE (12) AND CAMERA (10) ARE SUCH THAT IT WOULD MAKE EFFECT OF A SHADOW MAGNIFICATION FOR PROCESSING PURPOSE.  THE LIGHT SOURCE IS POSITIONED AT A DISTANCE FROM THE INFANT OR CHILD TO CREATE A SHADOW BEHIND THE INFANT OR CHILD, AND THE VIDEO CAMERA MONITORS THE MOVEMENT OF SHADOW CREATED.  FIGURE 3
Patent MY-177591-A (MY)
Title: Nk1 receptor antagonist composition
Inventor: TAKUYA UOZUMI
Filed: 2007-10-12
Abstract: An NK1 receptor antagonist composition of the present invention uses maltooligosaccharide having an NK1 receptor antagonistic activity as an active ingredient. A suitable amount of the maltooligosaccharide to be blended in the NK1 receptor antagonist composition of the present invention is 0.000001 to 70% by weight. The NK1 receptor antagonist composition of the present invention is prepared for use into various forms of external agents, internal medicines, foods and beverages by blending various materials as the ingredients other than the active ingredient. The NK1 receptor antagonist composition of the present invention has high safety for being used for pharmaceuticals and has satisfactory therapeutic effects.
Patent MY-167751-A (MY)
Title: Structure with light for illuminating funerary urns housed therein
Inventor: FANG WEN-CHIEH
IPC: E04H13/00
Filed: 2009-12-24
Abstract: A niche structure of columbarium (1) includes a plurality of illumination assemblies (3) comprising a light source (37); a plurality of rectangular niches each surrounded by the illumination assemblies (3) by threadedly fastening the illumination assemblies (3) therearound; and a plurality of boxes (4) each for storing an urn (6) and removably disposed in the niche. Light emitted by the light source (37) brings about a starry night effect. An LED device (4221) is provided in the box (4) such that closing door (42) of the box (4) will cause the LED device (4221) to emit light toward the door (42).
Patent MY-154753-A (MY)
Title: Method of installing an underwater riser
Inventor: PHILIPPE ESPINASSE
IPC: E21B43/013
Filed: 2009-02-18
Abstract: A METHOD OF INSTALLING AN UNDERWATER RISER INCLUDES ANCHORING AN INSTALLATION TO THE SEABED (10); COUPLING A TUBULAR PIPE (20) TO THE INSTALLATION; EQUIPPING THE INSTALLATION WITH A SUBMERSIBLE FLOAT; SUBMERGING THE FLOAT (18) AND THE PIPE (20), WHILE THE FLOAT (18) AND THE PIPE (20), ARE BEING HELD FROM A SURFACE VESSEL (12); A CABLE AND A RETURN DEVICE (34) ARE INSTALLED ON THE SEABED INSTALLATION (24) SO THAT THE CABLE CAN BE CONNECTED TO THE PIPE (20); ATTACHING A SUBMERGED HAULING BUOY TO THE HAULING CABLE; THEN REMOVING BALLAST FROM THE FLOAT (18) IN ORDER TO COMPENSATE FOR THE TENSILE FORCES CORRESPONDING TO THE WEIGHT OF THE FLOAT (18) AND THE PIPE (20) AND TO SOME OF THE LOAD APPLIED TO THE CABLE; AND FINALLY, ANCHORING OF THE HAULING BUOY TO THE INSTALLATION AND GRADUALLY RELEASING THE FLOAT (18).
Patent MY-152752-A (MY)
Title: Coating agent, substrate for mounting optical semiconductor element using same, and optical semiconductor device
Inventor: NAOYUKI URASAKI
IPC: B05D5/00
Filed: 2009-09-25
Abstract: THE COATING AGENT OF THE INVENTION IS A COATING AGENT TO BE USED BETWEEN CONDUCTOR MEMBERS, COMPRISING A THERMOSETTING RESIN, A WHITE PIGMENT, A CURING AGENT AND A CURING CATALYST, THE COATING AGENT TO BE USED BETWEEN CONDUCTOR MEMBERS HAVING A WHITE PIGMENT CONTENT OF 10-85 VOL% BASED ON THE TOTAL SOLID VOLUME OF THE COATING AGENT, AND A WHITENESS OF AT LEAST 75 WHEN THE CURED PRODUCT OF THE COATING AGENT HAS BEEN ALLOWED TO STAND AT 200°C FOR 24 HOURS. [FIG. 1]
Patent MY-153929-A (MY)
Title: Flushable multilayer film
Inventor: MICHAEL SCHUHMANN
IPC: B32B27/30
Filed: 2009-12-16
Abstract: MULTILAYER FILM, COMPRISING AN AT LEAST FLUSHABLE, THERMOPLASTIC LAYER COMPOSITE MADE OF AT LEAST ONE LAYER WHICH IS AT LEAST COMMINUTABLE VIA EXPOSURE TO WATER AND IS RESISTANT TO COLD WATER OR CAN ONLY BE DISSOLVED SLOWLY THEREIN, FORMED OF AT LEAST ONE AT LEAST PARTIALLY SAPONIFIED POLYVINYL ACETATE HAVING A LAYER THICKNESS OF <10 µM, AND AT LEAST ONE LAYER SOLUBLE IN COLD WATER COMPRISED OF AT LEAST ONE AT LEAST PARTIALLY SAPONIFIED POLYVINYL ACETATE AND AT LEAST ONE SUBSTANCE THAT INCREASES THE WATER SOLUBILITY, SELECTED FROM THE GROUP CONSISTING OF BIODEGRADABLE POLYMERS, SURFACTANTS, INORGANIC PIGMENTS AND FILLERS, AND FLUSHABLE PACKAGES PRODUCED THEREFROM.
Patent OA-11953-A (OA)
Title: Method for identification of shallow water flow hazards using marine seismic data.
Inventor: HUFFMAN ALAN ROYCE
IPC: G01V1/30
Filed: 2000-06-07
Abstract: The problem of detecting sedimentary formations having an abnormally high fluid pressure that are underneath a relatively impermeable formation, (118), having normal fluid pressures is addressed. At shallow depths, a formation with abnormally high fluid pressure has a shear velocity that is close to zero, (134), and is thus significantly different from the shear velocity of overlying sediments, (118). The high shear wave-velocity contrast is detected by measuring, (116), a change in the amplitude of seismic waves reflected from the top of the abnormally pressured formation, (130). This may be done by an amplitude versus offset (AVO) analysis of the reflected amplitudes of compressional or shear reflections. Measurements of the amplitude of reflected shear waves from a formation, (118), at some depth below the anomalous zone are may also be used to detect the presence of abnormally pressured intervals with low shear velocity, (138), and high shear wave attenuation.
Patent RU-2003124071-A (RU)
IPC: D21C11/00
Filed: 2002-01-23
Abstract: Oxidized white liquor is heat treated to increase the concentration of PSUV measured at 285 or 286 nm or PSVIS measured at 416 nm and the PSUV/PSGR or PSVIS/PSGR ratio, whereby the content of active polysulphide in the total polysulphide is increased which active polysulphide can be exploited to increase pulp yield in Kraft pulping.
Patent RU-2004114225-A (RU)
IPC: A61P11/00
Filed: 2002-09-27
Abstract: The present invention is an orally administered liquid pharmaceutical composition that demonstrates excellent physical stability while delivering concentrated levels of the pharmaceutical active(s). Specifically, these compositions for extended periods do not allow the active to precipitate or settle out of solution. Among the advantages of this invention is that the compositions do not require agitation/shaking prior to use as a method to re-suspend or dissolve active drug material to insure even and consistent dosing.
Patent RU-2006101764-A (RU)
IPC: A61K/
Filed: 2004-06-25
Abstract: A crystalline form of epirubicin hydrochloride, named herein as "type II" crystalline epirubicin hydrochloride, has excellent thermal stability. Type II crystalline epirubicin hydrochloride has a powder X-ray diffraction pattern having average values of diffraction angle (2theta) and relative intensity P(%) as presented in the following table: <tables id="TABLE-US-00001" num="00001"> <table frame="none" colsep="0" rowsep="0"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="35pt" align="left"/> <colspec colname="1" colwidth="42pt" align="center"/> <colspec colname="2" colwidth="140pt" align="center"/> <thead> <row> <entry/> <entry namest="offset" nameend="2" align="center" rowsep="1"/> </row> <row> <entry/> <entry>Diffraction</entry> <entry/> </row> <row> <entry/> <entry>Angle</entry> <entry>Relative Intensity</entry> </row> <row> <entry/> <entry>2Theta</entry> <entry>P (%)</entry> </row> <row> <entry/> <entry namest="offset" nameend="2" align="center" rowsep="1"/> </row> </thead> <tbody valign="top"> <row> <entry/> </row> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="35pt" align="left"/> <colspec colname="1" colwidth="42pt" align="char" char="."/> <colspec colname="2" colwidth="140pt" align="char" char="."/> <tbody valign="top"> <row> <entry/> <entry>5.236</entry> <entry>9.8</entry> </row> <row> <entry/> <entry>9.212</entry> <entry>12.5</entry> </row> <row> <entry/> <entry>13.732</entry> <entry>15.5</entry> </row> <row> <entry/> <entry>16.446</entry> <entry>4.8</entry> </row> <row> <entry/> <entry>18.234</entry> <entry>5</entry> </row> <row> <entry/> <entry>21.114</entry> <entry>9.7</entry> </row> <row> <entry/> <entry>22.529</entry> <entry>25.5</entry> </row> <row> <entry/> <entry>24.071</entry> <entry>29.9</entry> </row> <row> <entry/> <entry>25.879</entry> <entry>18.4</entry> </row> <row> <entry/> <entry>27.762</entry> <entry>16.5</entry> </row> <row> <entry/> <entry>29.757</entry> <entry>10.1</entry> </row> <row> <entry/> <entry>34.392</entry> <entry>4.4</entry> </row> <row> <entry/> <entry>38.157</entry> <entry>13.1</entry> </row> <row> <entry/> <entry>44.293</entry> <entry>5.9</entry> </row> <row> <entry/> <entry>64.699</entry> <entry>7.7</entry> </row> <row> <entry/> <entry>77.815</entry> <entry>100.</entry> </row> <row> <entry/> <entry namest="offset" nameend="2" align="center" rowsep="1"/> </row> </tbody> </tgroup> </table> </tables>
Patent RU-2006114824-A (RU)
IPC: A61B17/00
Filed: 2006-05-02
Abstract: A surgical instrument (10) for applying an anastomotic ring device comprises a handle (13) connected to an anastomotic ring deployment mechanism (20) by a shaft (15). The shaft has at least one articulation joint (24) that is capable of articulating in at least one direction to allow the surgeon to alter the angle of approach in order to compensate for disadvantageous placement of a trocar port through which the instrument is inserted. An articulation joint may comprise a ribbed member. One or more cables may be used to effect articulation of the articulation joint.
Patent RU-2006144506-A (RU)
Title: Способ дифференциальной диагностики заболеваний височно-нижнечелюстного сустава
IPC: A61B8/00
Filed: 2006-12-13
Abstract: Способ дифференциальной диагностики заболеваний височно-нижнечелюстного сустава путем изучения звуковых сигналов контактирующих поверхностей при движении, отличающийся тем, что изучают звуковые сигналы в диапазоне от 30 до 5000 Гц, при выявлении преимущественно в диапазоне 1 от 30 до 300 Гц диагностируют артроз сустава, при диапазоне 2 от 30 до 600 Гц - артрит, при диапазоне 330-5000 Гц дисфункция височно-нижнечелюстного сустава.
Patent RU-2007101702-A (RU)
IPC: C07D495/04
Filed: 2005-06-15
Abstract: A compound of formula (I) wherein R is methyl, ethyl, n-propyl, iso-propyl, n-butyl or allyl; R' is hydrogen, C1-C4 alkyl, C1-C3 alkoxy; halogen, trifluoromethyl or OCHxFy, R'' is hydrogen, fluoro or chloro, that R'' being fluoro or chloro only when R' is fluoro or chloro; R3 is hydrogen or C1-C5 alkyl R4 is hydrogen, CH2OCOC(CH3)3, pharmaceutically acceptable inorganic or organic cations, or COR4' wherein R4' is C1-C5 alkyl, phenyl, benzyl or phenethyl; R7 is methyl or ethyl; one of A and B is sulphur and the other is C-R2; when A is S, R2 is selected from hydrogen and methyl, with the proviso that R2 is methyl only when R3 is not hydrogen; and when B is S, R2 is hydrogen; and any tautomer thereof. A pharmaceutical composition comprising a compound of formula (I), a method of treating malignant tumours or diseases resulting from autoimmunity or pathologic inflammation.
Patent RU-2007129454-A (RU)
Title: Электротеплоаккумулятор (парогенератор)
IPC: F22B1/00
Filed: 2007-07-31
Abstract: 1. Электротеплоаккумулятор-парогенератор в качестве круглосуточного обогревателя, водонагревателя, парогенератора для бытовых нужд, например, для сауны, (бани), содержащий электронагреватели, теплоизоляцию, кожух, средства термоконтроля, бак с водой, отличающийся тем, что он содержит тигель с теплоносителем, например с алюминием.2. Устройство по п.1, отличающееся тем, что в тигле с алюминием находится паровая камера с трубками для входа воды и выхода пара.3. Устройство по пп.1 и 2, отличающееся тем, что оно выполнено, например, в виде полой стальной плиты.
Patent RU-2007137435-A (RU)
IPC: A61K31/495
Filed: 2006-03-23
Abstract: The invention describes a pharmaceutical composition of a slow-release preparation in the form of pellets for the treatment of vertigo of any genesis. Thus, a pharmaceutical composition is described that contains cinnarizine and dimenhydrinate, wherein the release of active ingredients is slowed down and the preparation is in the form of pellets. In addition, the pharmaceutical composition contains binding agent, slow-release agent and fillers.
Patent RU-2007138922-A (RU)
IPC: B01F23/2373
Filed: 2006-03-17
Abstract: A system (1) for carbonizing a liquid comprising a liquid inlet (2), a pressurized tank for carbon dioxide (3), a mixing tank (4) for receiving a mix of carbon dioxide and liquid, the system further comprising a first passage for feeding liquid and a second passage for feeding carbon dioxide. The liquid and carbon dioxide is further received by the mixing tank (4) at its lower portion.
Patent RU-2007142557-A (RU)
Title: Матричная таблетка с основой для пролонгированного высвобождения триметазидина дигидрохлорида, способ ее получения и способ лечения
IPC: A61K9/22
Filed: 2007-11-20
Abstract: 1. Матричная таблетка с основой для пролонгированного высвобождения триметазидина или его фармацевтически приемлемой соли, состоящая из ядра, включающего матрицеобразующий компонент, и покрывающей ядро оболочки, отличающаяся тем, что ядро содержит 15-25 мас.% триметазидина или его фармацевтически приемлемой соли, а матрицеобразующий компонент представляет собой комбинацию гидроксипропилцеллюлозы и коповидона, при количественном содержании гидроксипропилцеллюлозы и коповидона 20,0-24,7 мас.% и 1,3÷8,0 мас.% соответственно. ! 2. Матричная таблетка с основой для пролонгированного высвобождения триметазидина или его фармацевтически приемлемой соли по п.1, отличающаяся тем, что она содержит 25,0÷30,0 мас.% микрокристаллической целлюлозы. ! 3. Матричная таблетка с основой для пролонгированного высвобождения триметазидина или его фармацевтически приемлемой соли по п.1, отличающаяся тем, что оболочка содержит селекоут. ! 4. Матричная таблетка с основой для пролонгированного высвобождения триметазидина или его фармацевтически приемлемой соли по п.1, отличающаяся тем, что она содержит кальций фосфат дигидрат в количестве 15-20 мас.%. ! 5. Матричная таблетка с основой для пролонгированного высвобождения триметазидина или его фармацевтически приемлемой соли по п.1, отличающаяся тем, что коповидон представляет собой Пласдон S-630. ! 6. Матричная таблетка с основой для пролонгированного высвобождения триметазидина или его фармацевтически приемлемой соли по п.1, отличающаяся тем, что она содержит стеариновую кислоту или ее соль в количестве 0,5-0,8 мас.%. ! 7. Матричная таблетка с основой для пролонгированного высвобождения триметазидина или е�
Patent RU-2007148219-A (RU)
Title: Способ обнаружения бактерий и тест-набор для их обнаружения
IPC: C12R1/01
Filed: 2002-10-24
Abstract: 1. Способ обнаружения бактерий Pasteurella trehalosi и/или Mannheimia haemolytica, отличающийся тем, что включает стадии получения образца из организма домашней птицы, где образец выбирают из группы, включающей кровь, сыворотку, плазму, тканевые соскобы, смывы, мазки, ткань, и анализ образца на присутствие бактерий Pasteurella trehalosi и/или Mannheimia haemolytica. ! 2. Способ по п.1, отличающийся тем, что присутствие бактерий Pasteurella trehalosi и/или Mannheimia haemolytica определяют с помощью иммунного анализа. ! 3. Способ по п.1, отличающийся тем, что присутствие бактерий Pasteurella trehalosi и/или Mannheimia haemolytica определяют с помощью методов молекулярной биологии. ! 4. Тест-набор для обнаружения, содержащий агент для определения наличия в нем обнаруживаемых в образце Pasteurella trehalosi и/или Mannheimia haemolytica.
Patent RU-2008102410-A (RU)
Title: Горизонтальный дисковый тепло- и массообменный аппарат
IPC: B01D3/00
Filed: 2008-01-25
Abstract: 1. Горизонтальный дисковый тепло- и массообменный аппарат, содержащий цилиндрический корпус с днищами, в верхней части которого установлены патрубки для подвода и отвода газа, а в нижней - патрубки для подвода и отвода жидкости, снабженный разделительными кольцевыми перегородками, образующими секции с внешними кольцевыми каналами, продольный вал, установленный с возможностью вращения в блоках подшипников с уплотнениями в днищах корпуса, а также установленными на вале и соосно ему поперечными сплошными и кольцевыми контактными дисками, которые установлены с зазором относительно сплошных дисков, вала и друг друга и частично погружены в жидкость, которые образуют контактные пакеты с центральными осевыми каналами в них, отличающийся тем, что разделительные кольцевые перегородки жестко закреплены относительно друг друга и корпуса распорными трубками, установленными на продольных шпильках, которые закреплены в корпусе, при этом сплошные контактные диски закреплены на вале совместно с кольцевыми контактными дисками и установленными между ними напротив разделительных кольцевых перегородок разделительными контактными дисками, образующими совместно ротор контактных дисков, который установлен в корпусе с минимальным зазором относительно поверхностей центральных отверстий разделительных кольцевых перегородок, при этом на боковых поверхностях контактных дисков выполнены гофры, причем гофры, выполненные на контактных дисках, между которыми ПГС протекает от центральных осевых каналов к внешним кольцевым каналам, формируют профиль каналов течения ПГС между КД, подобный профилю каналов центробежных насос�